BioJapan 2026 is Asia’s premier biotechnology partnering event and the world’s longest‑running biotech exhibition, celebrating its 40th anniversary in 2026. It will be held 7–9 October 2026 at PACIFICO Yokohama, bringing together global leaders across pharmaceuticals, biotech, academia, digital health, regenerative medicine, and investment.

The congress is built on three pillars: Exhibition, Seminars, and Partnering, creating a high‑value platform for open innovation. Past editions have attracted 22,000+ attendees and facilitated 25,000+ business meetings, underscoring its role as a major hub for collaboration and licensing.

BioJapan 2026 is co‑located with Regenerative Medicine Japan and healthTECH JAPAN, expanding its scope to cutting‑edge fields such as regenerative therapies, digital diagnostics, AI‑driven healthcare, and advanced manufacturing.

The event features keynote lectures, sponsor seminars, investor forums, and presentations from leading researchers and industry executives. Exhibitors and participants gain access to BioJapan’s original partnering system, enabling targeted meetings for co‑development, technology transfer, and strategic alliances.

With its strong international participation and focus on breakthrough science, BioJapan 2026 remains a cornerstone event driving the future of biotechnology innovation in Asia and beyond.